The FOS transcription factor negatively regulates MAFF to control myometrial cell contractility
Abstract
Inflammatory signaling in the human myometrium drives uterine activation and labor, yet its transcriptional regulation remains incompletely understood. We previously identified MAFF as an inflammation-inducible transcription factor in human myometrial cells. Here, we investigated whether FOS regulates MAFF expression and whether MAFF contributes to myometrial cell contractility. FOS knockdown increased MAFF mRNA approximately 1.5-fold under basal conditions and 1.7-fold following IL1B stimulation, accompanied by increased MAFF protein after 1 h of IL1B exposure. ChIP-qPCR demonstrated FOS occupancy in the MAFF promoter region, supporting a negative regulatory relationship. Functionally, CRISPR/Cas9-generated MAFF-deficient cells displayed approximately 15–25% lower basal contractility than wild-type cells. Contractile responses to IL1B varied among the MAFF-deficient clones, although they generally remained less contractile than wild-type cells. MAFF overexpression increased contraction in wildtype cells (by 7%) and two of three MAFF-deficient clones (by 4–8%). Conversely, FOS overexpression reduced contraction in wild-type cell (−6.7%) but had no significant effect in the MAFF-deficient clones. Together, these findings identify FOS as a negative regulator of MAFF expression and support a role for MAFF in modulating myometrial cell contractility.
Related
- Mast cell-derived histamine negatively regulates hematopoiesis
- IKK2/β mediated phosphorylation of transcription factor Ets2 at site(s) distal to DNA binding domain negatively modulates its DNA binding activity
- Analysis of High‐Risk Factors for Failure of Bleeding Control in Enhanced Myometrial Vascularity Treated With Uterine Artery Embolization
- The Spleen Negatively Regulates the Acute Phase of Experimental Autoimmune Encephalomyelitis in Mice
- DDX3x Regulates NINJ1 Transcription via Histone Lactylation in Sepsis Associated‐Acute Kidney Injury
BibTeX
@article{orozcoalonso2026transcription,
title = {{The FOS transcription factor negatively regulates MAFF to control myometrial cell contractility}},
author = {Eduardo Orozco-Alonso and Palak Gujral and James Saliba and Volker Blank},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73274-4},
url = {https://www.nature.com/articles/s41598-026-73274-4},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The FOS transcription factor negatively regulates MAFF to control myometrial cell contractility
AU - Eduardo Orozco-Alonso
AU - Palak Gujral
AU - James Saliba
AU - Volker Blank
PY - 2026
DA - 2026/10/03
JO - Scientific Reports
DO - 10.1038/s41598-026-73274-4
UR - https://www.nature.com/articles/s41598-026-73274-4
AB - Inflammatory signaling in the human myometrium drives uterine activation and labor, yet its transcriptional regulation remains incompletely understood. We previously identified MAFF as an inflammation-inducible transcription factor in human myometrial cells. Here, we investigated whether FOS regulates MAFF expression and whether MAFF contributes to myometrial cell contractility. FOS knockdown increased MAFF mRNA approximately 1.5-fold under basal conditions and 1.7-fold following IL1B stimulation, accompanied by increased MAFF protein after 1 h of IL1B exposure. ChIP-qPCR demonstrated FOS occupancy in the MAFF promoter region, supporting a negative regulatory relationship. Functionally, CRISPR/Cas9-generated MAFF-deficient cells displayed approximately 15–25% lower basal contractility than wild-type cells. Contractile responses to IL1B varied among the MAFF-deficient clones, although they generally remained less contractile than wild-type cells. MAFF overexpression increased contraction in wildtype cells (by 7%) and two of three MAFF-deficient clones (by 4–8%). Conversely, FOS overexpression reduced contraction in wild-type cell (−6.7%) but had no significant effect in the MAFF-deficient clones. Together, these findings identify FOS as a negative regulator of MAFF expression and support a role for MAFF in modulating myometrial cell contractility.
SN - 2045-2322
ER -